X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2026-02-26 | ABCL | Abcellera Biologics Inc. | Thermopylae Holdings Ltd. | 10% | P - Purchase | $3.27 | +177,457 | 56,096,097 | 0% | +$580,284 | ||||||
2026-02-27 | ABCL | Abcellera Biologics Inc. | Booth Andrew | CFO | P - Purchase | $3.42 | +42,600 | 326,559 | +15% | +$145,692 | ||||||
2026-02-27 | ABCL | Abcellera Biologics Inc. | Thermopylae Holdings Ltd. | 10% | P - Purchase | $3.44 | +38,000 | 56,134,097 | 0% | +$130,720 | ||||||
2026-02-27 | ABSI | Absci Corp | Pangalos Menelas N | Dir | P - Purchase | $2.74 | +75,095 | 189,055 | +66% | +$205,760 | ||||||
2026-02-26 | ACVA | Acv Auctions Inc. | Waterman Michael | Chief Sales Officer | P - Purchase | $4.66 | +214,600 | 569,102 | +61% | +$1,000,036 | ||||||
2026-01-16 | AERA | Ai Era Corp. | Deng Chiyuan | CEO, 10% | P - Purchase | $0.86 | +130,000 | 2,192,489 | +6% | +$111,800 | ||||||
2026-03-02 | AGL | Agilon Health, Inc. | Shaker Benjamin | Chief Markets Officer | P - Purchase | $0.60 | +500,000 | 1,367,674 | +58% | +$301,050 | ||||||
| M | 2026-03-03 | AIRS | Airsculpt Technologies, Inc. | Chernett Jorey | 10% | P - Purchase | $1.75 | +110,000 | 6,352,611 | +2% | +$192,900 | |||||
2026-02-24 | ALIT | Alight, Inc. / Delaware | Verma Rohit | CEO | P - Purchase | $0.77 | +100,000 | 1,022,883 | +11% | +$77,040 | ||||||
2026-02-02 | ALXO | Alx Oncology Holdings Inc | Goodman Corey S | Dir, 10% | P - Purchase | $1.57 | +3,184,713 | 13,052,008 | +32% | +$4,999,999 | ||||||
| M | 2026-02-27 | APCX | Apptech Payments Corp. | Lord Albert L | Dir | P - Purchase | $0.31 | +100,000 | 3,270,394 | +3% | +$31,350 | |||||
| M | 2026-02-24 | APCX | Apptech Payments Corp. | Lord Albert L | Dir | P - Purchase | $0.34 | +150,000 | 3,170,394 | +5% | +$51,040 | |||||
| M | 2026-02-18 | ARAY | Accuray Inc | Mayer Steven F | Dir | P - Purchase | $0.53 | +195,125 | 1,490,745 | +15% | +$103,797 | |||||
2026-02-20 | ARAY | Accuray Inc | Mayer Steven F | Dir | P - Purchase | $0.56 | +54,875 | 1,545,620 | +4% | +$30,878 | ||||||
2026-02-27 | BCHT | Birchtech Corp. | Macpherson Richard | Pres, CEO, 10% | P - Purchase | $2.40 | +312,500 | 2,955,095 | +12% | +$750,000 | ||||||
| M | 2026-02-24 | BLIN | Bridgeline Digital, Inc. | Ketslakh Michael | Dir | P - Purchase | $0.85 | +13,041 | 486,883 | +3% | +$11,085 | |||||
| M | 2026-02-17 | BLIN | Bridgeline Digital, Inc. | Kahn Roger E. | Pres, CEO, 10% | P - Purchase | $0.78 | +54,301 | 1,764,280 | +3% | +$42,206 | |||||
2026-02-13 | CHGG | Chegg, Inc | Rosensweig Daniel | Pres, CEO, EXEC COB | P - Purchase | $0.56 | +100,000 | 7,674,917 | +1% | +$56,360 | ||||||
2026-02-13 | CHUC | Charlie'S Holdings, Inc. | Carmines Edward | Dir | P - Purchase | $0.20 | +250,000 | 2,256,481 | +12% | +$50,000 | ||||||
2026-02-13 | CHUC | Charlie'S Holdings, Inc. | King Michael D | Dir | P - Purchase | $0.20 | +500,000 | 6,750,001 | +8% | +$100,000 | ||||||
2026-02-13 | CHUC | Charlie'S Holdings, Inc. | Montesano Matthew P | CFO | P - Purchase | $0.20 | +100,000 | 2,825,409 | +4% | +$20,000 | ||||||
2026-02-13 | CHUC | Charlie'S Holdings, Inc. | Sicignano Henry III | Pres | P - Purchase | $0.20 | +250,000 | 9,950,001 | +3% | +$50,000 | ||||||
2026-02-13 | CHUC | Charlie'S Holdings, Inc. | Stump Ryan | COO | P - Purchase | $0.20 | +250,000 | 29,701,755 | +1% | +$50,000 | ||||||
2026-02-17 | CMRC | Commerce.Com, Inc. | Siminoff Ellen F | Exec Chair | P - Purchase | $2.94 | +100,000 | 431,319 | +30% | +$294,080 | ||||||
2026-03-02 | CMTG | Claros Mortgage Trust, Inc. | McGillis Mike | Pres, CFO | P - Purchase | $2.34 | +20,000 | 603,007 | +3% | +$46,792 | ||||||
2026-02-27 | CMTG | Claros Mortgage Trust, Inc. | Mack Richard | CEO, COB | P - Purchase | $2.41 | +50,000 | 2,717,330 | +2% | +$120,355 | ||||||
2026-02-24 | CMTG | Claros Mortgage Trust, Inc. | Walter W Edward | Dir | P - Purchase | $2.28 | +25,000 | 71,475 | +54% | +$56,895 | ||||||
2026-02-19 | CNDT | Conduent Inc | Fucci Michael | Dir | P - Purchase | $1.44 | +60,000 | 166,102 | +57% | +$86,580 | ||||||
2026-02-18 | CNDT | Conduent Inc | Palau Hernandez Margarita | Dir | P - Purchase | $1.45 | +50,000 | 452,996 | +12% | +$72,650 | ||||||
| M | 2026-02-18 | CNDT | Conduent Inc | Agadi Harshavardhan V | CEO | P - Purchase | $1.43 | +220,000 | 2,116,829 | +12% | +$313,720 | |||||
2026-02-20 | CNDT | Conduent Inc | Agadi Harshavardhan V | CEO | P - Purchase | $1.56 | +117,099 | 2,233,928 | +6% | +$182,909 | ||||||
| D | 2026-02-17 | CNVS | Cineverse Corp. | McGurk Christopher J | CEO, COB | P - Purchase | $2.00 | +75,000 | 671,045 | +13% | +$150,000 | |||||
| D | 2026-02-17 | CNVS | Cineverse Corp. | Loffredo Gary S | CLO, Secretary, Sr Advisor | P - Purchase | $2.00 | +30,000 | 200,337 | +18% | +$60,000 | |||||
| D | 2026-02-17 | CNVS | Cineverse Corp. | Opeka Erick | CSO, Pres | P - Purchase | $2.00 | +30,000 | 224,146 | +15% | +$60,000 | |||||
| D | 2026-02-17 | CNVS | Cineverse Corp. | Macias Yolanda | Chief Motion Pictures Officer | P - Purchase | $2.00 | +30,000 | 121,906 | +33% | +$60,000 | |||||
| D | 2026-02-17 | CNVS | Cineverse Corp. | Torres Mark | Chief People Officer | P - Purchase | $2.00 | +25,000 | 183,274 | +16% | +$50,000 | |||||
| D | 2026-02-17 | CNVS | Cineverse Corp. | Lindsey Mark Wayne | CFO | P - Purchase | $2.00 | +35,000 | 154,168 | +29% | +$70,000 | |||||
| D | 2026-02-17 | CNVS | Cineverse Corp. | Huidor Mark Antonio | Pres Tech, Chief Product Off | P - Purchase | $2.00 | +37,500 | 190,061 | +25% | +$75,000 | |||||
| D | 2026-02-12 | COCH | Envoy Medical, Inc. | Taylor Glen A | 10% | P - Purchase | $0.40 | +18,750,000 | 29,040,049 | +182% | +$7,500,000 | |||||
| D | 2026-02-12 | COCH | Envoy Medical, Inc. | Brynelsen Charles | Dir | P - Purchase | $0.40 | +1,000,000 | 1,050,000 | >999% | +$400,000 | |||||
| D | 2026-02-12 | COCH | Envoy Medical, Inc. | Lucas Brent T. | CEO | P - Purchase | $0.40 | +62,500 | 297,090 | +27% | +$25,000 | |||||
| D | 2026-02-12 | COCH | Envoy Medical, Inc. | Kantor Susan | Dir | P - Purchase | $0.40 | +96,150 | 174,037 | +123% | +$38,460 | |||||
| D | 2026-02-12 | COCH | Envoy Medical, Inc. | Potashnick Robert | Interim CFO | P - Purchase | $0.40 | +212,500 | 212,500 | New | +$85,000 | |||||
| D | 2026-02-12 | COCH | Envoy Medical, Inc. | Patel Mona Chetan | Dir | P - Purchase | $0.40 | +312,500 | 332,500 | >999% | +$125,000 | |||||
2026-02-06 | COCP | Cocrystal Pharma, Inc. | Frost Phillip Md Et Al | Dir, 10% | P - Purchase | $0.95 | +50,000 | 1,915,651 | +3% | +$47,280 | ||||||
2026-02-24 | COCP | Cocrystal Pharma, Inc. | Frost Phillip Md Et Al | Dir, 10% | P - Purchase | $1.00 | +20,000 | 1,935,651 | +1% | +$19,952 | ||||||
2026-02-11 | COSM | Cosmos Health Inc. | Siokas Grigorios | CEO, 10% | P - Purchase | $0.41 | +291,262 | 8,473,382 | +4% | +$120,000 | ||||||
2026-02-12 | COSM | Cosmos Health Inc. | Siokas Grigorios | CEO, 10% | P - Purchase | $0.37 | +388,532 | 8,861,914 | +5% | +$145,000 | ||||||
2026-02-10 | COTY | Coty Inc. | Mercier Laurent | CFO | P - Purchase | $2.65 | +5,000 | 500,031 | +1% | +$13,250 | ||||||
| M | 2026-02-26 | EDSA | Edesa Biotech, Inc. | Nijhawan Pardeep | CEO, 10% | P - Purchase | $1.96 | +50,571 | 1,115,241 | +5% | +$99,176 | |||||
2026-03-03 | EDSA | Edesa Biotech, Inc. | Nijhawan Pardeep | CEO, 10% | P - Purchase | $3.63 | +10,000 | 1,128,241 | +1% | +$36,300 | ||||||
2026-02-27 | EHTH | Ehealth, Inc. | Duke Derrick A | CEO | P - Purchase | $1.38 | +187,969 | 487,969 | +63% | +$259,397 | ||||||
| M | 2026-02-02 | EMPD | Empery Digital Inc. | Atg Capital Opportunities Fund LP | 10% | P - Purchase | $4.68 | +691,145 | 4,500,000 | +18% | +$3,232,479 | |||||
| AM | 2026-01-28 | EMPD | Empery Digital Inc. | Atg Capital Management LP | 10% | P - Purchase | $4.94 | +428,626 | 3,808,855 | +13% | +$2,115,728 | |||||
| AM | 2026-02-02 | EMPD | Empery Digital Inc. | Atg Capital Management LP | 10% | P - Purchase | $4.68 | +691,145 | 4,500,000 | +18% | +$3,232,479 | |||||
2026-02-09 | ENTX | Entera Bio Ltd. | Ellis Sean | Dir | P - Purchase | $1.24 | +18,000 | 178,098 | +11% | +$22,320 | ||||||
2026-02-09 | ENTX | Entera Bio Ltd. | Rubin Steven D | Dir | P - Purchase | $1.20 | +10,000 | 10,000 | New | +$12,000 | ||||||
2026-02-10 | ENTX | Entera Bio Ltd. | Germano Geno J | Dir | P - Purchase | $1.49 | +20,000 | 0 | -100% | +$29,800 | ||||||
2026-02-10 | ENTX | Entera Bio Ltd. | Taitel Haya | Dir | P - Purchase | $1.48 | +7,500 | 0 | -100% | +$11,100 | ||||||
| D | 2026-02-10 | ERNA | Ernexa Therapeutics Inc. | Cherington Charles | 10% | P - Purchase | $0.50 | +4,000,000 | 6,779,440 | +144% | +$2,000,000 | |||||
2026-03-02 | FBLG | Fibrobiologics, Inc. | Davis Jason | CFO | P - Purchase | $0.41 | +70,000 | 70,000 | New | +$28,973 | ||||||
| M | 2026-03-02 | FBLG | Fibrobiologics, Inc. | O'Heeron Pete | CEO | P - Purchase | $0.38 | +51,500 | 5,958,147 | +1% | +$19,531 | |||||
2026-02-27 | FBLG | Fibrobiologics, Inc. | Garcia Ruben A | GC | P - Purchase | $0.33 | +40,000 | 180,000 | +29% | +$13,056 | ||||||
2026-02-02 | FEAM | 5E Advanced Materials, Inc. | Bep Special Situations IV LLC | Dir, 10% | P - Purchase | $2.00 | +4,000,000 | 12,130,997 | +49% | +$8,000,000 | ||||||
2026-01-14 | FEED | Envue Medical, Inc. | Glibert Christian Michael | 10% | P - Purchase | $2.67 | +240,000 | 240,000 | New | +$640,800 | ||||||
| D | 2026-02-10 | FIEE | Fiee, Inc. | Elements Corporate Services Ltd | 10% | P - Purchase | $1.29 | +2,138,181 | 3,119,830 | +218% | +$2,758,253 | |||||
2026-02-17 | GGT | Gabelli Multimedia Trust Inc. | Bogan Elizabeth C | Dir | P - Purchase | $4.05 | +2,700 | 2,700 | New | +$10,922 | ||||||
2026-02-24 | GGT | Gabelli Multimedia Trust Inc. | Gabelli Mario J | Control Person of Adviser | P - Purchase | $4.06 | +25,000 | 2,679,050 | +1% | +$101,460 | ||||||
| M | 2026-02-18 | GNSS | Genasys Inc. | Dodd William H | Dir | P - Purchase | $1.98 | +25,457 | 129,163 | +25% | +$50,405 | |||||
| D | 2026-02-23 | IBATF | International Battery Metals Ltd. | Warnock Jacob Aaron | Dir, 10% | P - Purchase | $0.08 | +26,427,053 | 109,326,104 | +32% | +$2,114,164 | |||||
2026-02-25 | IPWR | Ideal Power Inc. | Somo David M | Pres, CEO | P - Purchase | $2.75 | +90,909 | 338,347 | +37% | +$250,000 | ||||||
| M | 2026-02-27 | ISPR | Ispire Technology Inc. | Wang Michael Xue | Co-CEO | P - Purchase | $2.39 | +5,000 | 1,466,882 | 0% | +$11,959 | |||||
| M | 2026-02-24 | ISPR | Ispire Technology Inc. | Wang Michael Xue | Co-CEO | P - Purchase | $2.32 | +8,000 | 1,461,882 | +1% | +$18,529 | |||||
| A | 2026-02-11 | JAGU | Jaguar Uranium Corp. | Isoenergy Ltd. | 10% | P - Purchase | $4.00 | +253,150 | 3,253,150 | +8% | +$1,012,600 | |||||
2026-02-11 | JAGU | Jaguar Uranium Corp. | Isoenergy Ltd. | 10% | P - Purchase | $4.00 | +250,000 | 3,250,000 | +8% | +$1,000,000 | ||||||
2026-02-27 | LAW | Cs Disco, Inc. | Friedrichsen Eric | CEO | P - Purchase | $2.90 | +15,500 | 1,508,172 | +1% | +$44,950 | ||||||
2026-02-09 | LAW | Cs Disco, Inc. | Offerdahl James | Dir | P - Purchase | $3.99 | +3,000 | 223,652 | +1% | +$11,970 | ||||||
2026-02-27 | LAW | Cs Disco, Inc. | Goodman Robert P | Dir | P - Purchase | $3.19 | +1,026,700 | 1,079,980 | >999% | +$3,275,173 | ||||||
| M | 2026-03-02 | LAW | Cs Disco, Inc. | Hill Scott A | Dir | P - Purchase | $3.38 | +50,000 | 273,230 | +22% | +$169,246 | |||||
| M | 2026-02-26 | LAW | Cs Disco, Inc. | Srinivasan Krishna | Dir | P - Purchase | $3.20 | +45,000 | 7,924,265 | +1% | +$143,850 | |||||
2026-02-05 | LEE | Lee Enterprises, Inc | Quint Digital Ltd | 10% | P - Purchase | $3.25 | +2,451,346 | 3,214,346 | +321% | +$7,966,875 | ||||||
| M | 2026-02-26 | LFVN | Lifevantage Corp | Dayton Judd | Dir | P - Purchase | $4.59 | +33,197 | 829,684 | +4% | +$152,422 | |||||
2026-01-21 | LNZA | Lanzatech Global, Inc. | Guardians of New Zealand Superannuation | 10% | P - Purchase | $4.43 | +969,858 | 1,302,492 | +292% | +$4,300,000 | ||||||
2026-02-27 | LRHC | La Rosa Holdings Corp. | Hrt Financial LP | 10% | P - Purchase | $1.07 | +14,584 | 48,596 | +43% | +$15,605 | ||||||
2026-02-27 | LRMR | Larimar Therapeutics, Inc. | Sherman Jeffrey W | Dir | P - Purchase | $5.00 | +5,000 | 5,000 | New | +$25,000 | ||||||
2026-02-27 | LRMR | Larimar Therapeutics, Inc. | Hamilton Thomas Edward | Dir | P - Purchase | $5.00 | +100,000 | 824,231 | +14% | +$500,000 | ||||||
2026-02-27 | LRMR | Larimar Therapeutics, Inc. | Flynn James E | * Director by Deputization, 10% | P - Purchase | $5.00 | +5,000,000 | 35,606,974 | +16% | +$25,000,000 | ||||||
2026-02-27 | LRMR | Larimar Therapeutics, Inc. | Thomas Frank E | Dir | P - Purchase | $5.00 | +5,000 | 7,000 | +250% | +$25,000 | ||||||
2026-02-09 | LSAK | Lesaka Technologies Inc | Mazanderani Ali | Exec COB | P - Purchase | $4.36 | +91,423 | 2,416,538 | +4% | +$398,604 | ||||||
2026-02-02 | LXRX | Lexicon Pharmaceuticals, Inc. | Invus Global Management, LLC | Dir, 10% | P - Purchase | $1.30 | +1,538,462 | 44,145,189 | +4% | +$2,000,001 | ||||||
| M | 2026-02-13 | LXRX | Lexicon Pharmaceuticals, Inc. | Debbane Raymond | Dir | P - Purchase | $1.31 | +268,497 | 51,408,909 | +1% | +$352,889 | |||||
| M | 2026-02-19 | LXRX | Lexicon Pharmaceuticals, Inc. | Debbane Raymond | Dir | P - Purchase | $1.47 | +150,000 | 51,558,909 | 0% | +$219,755 | |||||
2026-02-23 | LXRX | Lexicon Pharmaceuticals, Inc. | Debbane Raymond | Dir | P - Purchase | $1.47 | +100,000 | 51,658,909 | 0% | +$147,000 | ||||||
2026-02-24 | MKZR | Mackenzie Realty Capital, Inc. | Dixon Robert E | CEO, Pres | P - Purchase | $3.64 | +5,000 | 136,665 | +4% | +$18,200 | ||||||
2026-02-27 | MQ | Marqeta, Inc. | Linville Judson C | Dir | P - Purchase | $3.93 | +25,570 | 223,876 | +13% | +$100,383 | ||||||
| M | 2026-02-25 | MYGN | Myriad Genetics Inc | Phanstiel S. Louise | Dir | P - Purchase | $4.73 | +104,507 | 315,070 | +50% | +$494,722 | |||||
| M | 2026-02-17 | NAII | Natural Alternatives International Inc | Ledoux Mark A | CEO, COB, 10% | P - Purchase | $2.58 | +4,500 | 721,542 | +1% | +$11,604 | |||||
2026-03-04 | NAUT | Nautilus Biotechnology, Inc. | Patel Sujal M | CEO, Pres,, Secretary, 10% | P - Purchase | $2.61 | +25,000 | 17,461,232 | 0% | +$65,238 | ||||||
| D | 2026-03-01 | NMTC | Neuroone Medical Technologies Corp | Wambeke David J. | Chief Business Officer | P - Purchase | $0.67 | +1,000,000 | 1,000,000 | New | +$670,400 | |||||
2026-02-24 | NOMA | Nomadar Corp. | Sport City Cadiz S.L. | 10% | P - Purchase | $4.66 | +415,935 | 7,648,946 | +6% | +$1,938,257 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |